Key result
Novel IsCHEMiA score predicts poststroke epilepsy, identifying up to a ~67% 1-year risk.
Cohort
Yes
Answers are grounded in this paper and cite their sources.
The IsCHEMiA score is a novel, internationally validated imaging-based risk score that can predict the risk of poststroke epilepsy after a first-ever ischemic stroke.
BACKGROUND AND OBJECTIVES: Stroke is one of the most common causes of adult-onset epilepsy. We aimed to develop a model to predict poststroke epilepsy (PSE) after a first-ever ischemic stroke, incorporating neuroimaging features of incident stroke. METHODS: We analyzed clinical and neuroimaging features of patients with first-ever acute ischemic stroke consecutively admitted to Massachusetts General Hospital, United States. We performed competing risk regression with all-cause mortality as a competing event and derived the final multivariable model using backward stepwise elimination by the Akaike Information Criterion. We externally validated the model in 3 international cohorts in Hong Kong (Queen Mary Hospital [HK-QMH], Ruttonjee Hospital [HK-RH]) and Japan (National Cerebral and Cardiovascular Center) by discrimination and calibration and compared its performance with the SeLECT and SeLECT2.0 scores. For example, an IsCHEMiA score of 3 predicts a low risk of PSE at 1 year (2%) and 5 years (6%) while an IsCHEMiA score ≥8 predicts a high risk at 1 year (67%) and 5 years (78%). DISCUSSION: The IsCHEMiA score is an improved and readily applicable predictive model developed and validated using international stroke cohorts in the modern era of reperfusion therapies. It serves as a foundation for personalized management and may guide future clinical trials on antiepileptogenic therapies in acute ischemic stroke.
No takes yet. Share an insight, caveat, or question.
Leung et al. (2026) conducted a cohort in first-ever acute ischemic stroke. IsCHEMiA score vs. SeLECT and SeLECT2.0 scores was evaluated on poststroke epilepsy (PSE) (p=<0.0001). The IsCHEMiA score predicts poststroke epilepsy, with a score of 3 indicating a 2% risk at 1 year and a score ≥8 indicating a 67% risk at 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: